FDA: Hospira recalls one lot of Propofol

Editor's Note

The Food and Drug Administration (FDA), on July 13, posted a nationwide recall by Hospira Inc (a Pfizer Company) of one lot (DX9067) of Propofol Injectable Emulsion, USP (containing Benzyl alcohol), 100 mL single patient use glass fliptop vial.

The recall was initiated because of visible particulate observed in a single vial during annual examination of retain samples.

Propofol is an intravenous general anesthetic and sedation drug used in the induction and maintenance of anesthesia or sedation.

To date, the company has not received any reports of adverse events associated with this issue. Distribution dates were June 10, 2020, through June 26, 2020.